You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 110 No. 1, January 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL SCIENCES
 This Article
 •References
 •Full text PDF
 •Correction
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Treatment of Retinopathy of Prematurity With Argon Laser Photocoagulation

Maurice B. Landers III, MD; Cynthia A. Toth, MD; H. Christopher Semple, MD; Lawrence S. Morse, MD, PhD

Arch Ophthalmol. 1992;110(1):44-47.


Abstract

• Fifteen eyes of nine infants were treated for retinopathy of prematurity by confluent photocoagulation of the avascular retina using an argon laser indirect ophthalmoscope. All treated eyes presented at or beyond threshold of stage 3 retinopathy of prematurity with "plus" disease. Three treated eyes had retinopathy of prematurity in zone I. Early complete regression of extraretinal proliferation was seen in 13 eyes. At 6 Januarys' minimum follow-up, 11 (73%) of the treated eyes demonstrated a favorable outcome, while four eyes (27%) progressed to an unfavorable outcome. No intraocular hemorrhages occurred during any laser treatment.



Author Affiliations

From the Department of Ophthalmology, University of California, Davis, Sacramento.


Footnotes

Accepted for publication July 31, 1991.

Reprint requests to Department of Ophthalmology, University of California, Davis, 1603 Alhambra Blvd, Sacramento, CA 95816 (Dr Landers).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The dipeptide arg-gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy.
Neu et al.
IOVS 2006;47:3151-3155.
ABSTRACT | FULL TEXT  

Near Confluent Laser Photocoagulation for the Treatment of Threshold Retinopathy of Prematurity
Rezai et al.
Arch Ophthalmol 2005;123:621-626.
ABSTRACT | FULL TEXT  

Non-ophthalmologist screening for retinopathy of prematurity
Saunders et al.
Br J Ophthalmol 2000;84:130-134.
ABSTRACT | FULL TEXT  

Dopamine use is an indicator for the development of threshold retinopathy of prematurity
Mizoguchi et al.
Br J Ophthalmol 1999;83:425-428.
ABSTRACT | FULL TEXT  

Three year visual outcome for treated stage 3 retinopathy of prematurity: cryotherapy versus laser
Pearce et al.
Br J Ophthalmol 1998;82:1254-1259.
ABSTRACT | FULL TEXT  

Timing of Initial Screening Examinations for Retinopathy of Prematurity
Hutchinson et al.
Arch Ophthalmol 1998;116:608-612.
ABSTRACT | FULL TEXT  

Diode Laser Photocoagulation for Retinopathy of Prematurity: Preliminary Results
McNamara et al.
Arch Ophthalmol 1992;110:1714-1716.
ABSTRACT  

Threshold Retinopathy of Prematurity Revisited
TASMAN
Arch Ophthalmol 1992;110:623-624.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.